Goldman Sachs Maintains Buy on Calumet, Lowers Price Target to $14
TD Cowen Maintains Calumet Inc(CLMT.US) With Hold Rating, Cuts Target Price to $14
Calumet Specialty Prods Is Maintained at Overweight by Wells Fargo
Calumet Analyst Ratings
Goldman Sachs Maintains Calumet Inc(CLMT.US) With Buy Rating, Cuts Target Price to $17
Calumet Upgraded From Sell at UBS, as Near-term RD Margin Headwind Seen Improving in H2
Calumet Analyst Ratings
Wells Fargo Maintains Calumet Inc(CLMT.US) With Buy Rating, Cuts Target Price to $28
Calumet Specialty Prods Is Maintained at Overweight by Wells Fargo
TD Cowen Downgrades Calumet Inc(CLMT.US) to Hold Rating, Cuts Target Price to $16
Calumet Analyst Ratings
Goldman Sachs Maintains Calumet Inc(CLMT.US) With Buy Rating, Announces Target Price $21
Calumet Analyst Ratings
Calumet Specialty Prods Cut to Sell From Neutral by UBS
Calumet Analyst Ratings
Calumet Analyst Ratings
Calumet Specialty Prods Is Maintained at Buy by TD Cowen
Calumet Analyst Ratings
Calumet Analyst Ratings
A Quick Look at Today's Ratings for Calumet Partners(CLMT.US), With a Forecast Between $25 to $27